[ad_1] Chennai, Biocon Biologics Ltd, a subsidiary of listed biopharmaceutical company Biocon Ltd, on Tuesday announced the completion of its acquisition of global biosimilars business of its partner Nasdaq listed Viatris Inc.Biocon Biologics and Viatris have obtained all applicable approvals from key global regulators, including the US Federal Trade Commission,...
Insights | Opinions | QnA
